A cross-sectional survey of 308 people living with HIV at Bule Hora University Teaching Hospital in Ethiopia found that 76.0 percent had good knowledge and a positive attitude toward dolutegravir-based antiretroviral therapy, while 94.2 percent reported good treatment practices. What the study adds…
A single-injection crossover study suggested participants preferred cabotegravir over lenacapavir. The faculty explain why they view the findings as a counseling aid rather than a reason to favor one agent. "What the CLARITY Study Means for Counseling on Long-Acting HIV…
Human immunodeficiency virus (HIV) is a virus that attacks the body's immune system. If it is not treated, it can lead to acquired immunodeficiency syndrome (AIDS). There is currently no effective cure. After people get HIV, they have it for…
Feedback | Friday, October 30, 2026 20/03/26 | 1:51 pm | Ministry of Health & Family Welfare | National AIDS Control Organisation (NACO) | Suraksha Sankalp Karyashala In his keynote address, Gupta underscored that HIV/AIDS continues to pose a significant public health challenge, necessitating sustained vigilance, innovation, and coordinated…
A selective inhibitor of the CDK12/CDK13-Cyclin K complex releases P-TEFb from its inhibitory 7SK snRNP reservoir and reverses HIV-1 latency in cell models and in cells from people living with HIV-1.
Uganda has begun local production of HIV self-test kits, with manufacturer Zakayo Industries Limited targeting to cut retail price from Shs25,000-30,000 to Shs7,000 and announcing first export consignment to Kenya. Development is expected to improve access to testing while reducing dependence on…
According to the editorial, addressing such inequalities has value beyond the populations directly affected. The point reflects a broader argument running through the piece: that HIV research must be understood as a global enterprise in which findings from one setting…
A scoping review published in BMC Public Health has synthesized three decades of research on how adolescent and young adult males find, evaluate and use sexual and reproductive health information, identifying persistent gaps between general awareness and functional knowledge of…
A new review finds checkpoint inhibitors are safe and effective for virologically suppressed people with HIV, while sub-Saharan Africa remains almost entirely excluded from immunotherapy trials. The unfinished work, the authors argue, is to test and deliver that evidence where…
A phase 4 randomised trial in India found the one-week IPC intradermal rabies regimen did not meet prespecified equivalence with the one-month UTRC regimen, though all participants achieved seroprotective antibody titres from day 14 to one year.
Testing, PrEP/PEP, treatment, and reducing stigma in sexual health care.
An article joins this feed when it matches these terms. Each one is also a search of its own.